Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzo-fused heterocyclic derivatives useful as agonists of GPR120

Benzo-fused heterocyclic derivatives useful as agonists of GPR120

US Patent 11254647 · Granted Feb 22, 2022

Estimated economic value: $192,742,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyruvate kinase activators for use in treating blood disorders2024
Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer2024
Inhibitors of cellular metabolic processes2024
Pyruvate kinase activators for use in treating blood disorders2024
Pyruvate kinase modulators and use thereof2024
Pyruvate kinase activators for use in treating blood disorders2023
Heterobicyclic inhibitors of MAT2A and methods of use for treating cancer2022
Pyruvate kinase modulators and use thereof2022
Pyruvate kinase activators for use in treating blood disorders2022
Inhibitors of cellular metabolic processes2022
Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptors2022
Pyruvate kinase activators for use in treating blood disorders2021